PreciseDx: PreciseDx Presents New Research on Their AI-Enabled Digital Test at 14th Annual European Breast Conference

The presentation, "Clinical validation of an artificial-intelligent (AI) enabled digital test using the patient's diagnostic breast biopsy to predict invasive breast cancer recurrence within 6-years," will be held 3/22/24 NEW YORK, March 22, 2024 /PRNewswire-PRWeb/ -- PreciseDx®, a...